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Sudden infant death syndrome (SIDS) is the main cause of post-perinatal infant mortality in the UK.' The syndrome is significantly associated with a number of features2": SIDS is uncommon in the first month of life and rare after the first year of life; the number of deaths peaks at two to three months of age, during the winter months and between 2400 and 0600 hours. In addition, there is persuasive evidence that viral infections of the upper respiratory tract predispose to SIDS.45 The "common bacterial toxin hypothesis" is the only hypothesis that explains the characteristic age distribution of SIDS. 6 The hypothesis states that a viral infection of the upper respiratory tract can lead to a "supra-infection" by commensal bacteria, and if this occurs at the same time as infantile immunoglobulins are at their lowest (at approximately two to three months of age) the baby is at risk of SIDS.
Studies have shown that SIDS victims, compared with matched healthy controls: (1) have a higher carriage rate of staphylococci and coliforms in their nasopharynx'; and (2) are significantly more likely to harbour a toxigenic strain in their nasopharynx.' It has also been shown that toxins from staphylococci and enterobacteria interact synergistically to produce a lethal effect following injection into chick embryos. 9 The aim of this study is to explore the role of endotoxin in SIDS by investigating the interaction between endotoxin and extracellular toxin preparations of staphylococci using a chick embryo bioassay. were used strictly in accordance with the manufacturer's instructions. All isolates were preserved at -20°C. Two staphylococcal species were tested, Staphylococcus aureus and Staphylococcus epidermidis. Isolates 1-7 were isolated from the PNS of SIDS victims whereas isolates 8-13 were isolated from the PNS of normal healthy infants (table 1) . The Staphylococcus isolates were tested for the production of enterotoxins A to D (SEA-SED) and toxic shock syndrome toxin-1 (TSST-1) (table 1) by Antonnette Wieneke (Central Public Health Laboratory, Colindale, London, UK) using the SET-RPLA kit (TD900, Unipath, Basingstoke, UK). The manufacturer's instructions were followed except that the dilutions of the culture filtrates used were 1 in 2, 1 in 10 and 1 in 100.11
TESTING OF TOXICITY
The bacterial isolates chosen were screened for lethal toxicity9l12 using a chick embryo assay system originally described by Eichhorn, '3 which has the advantage of sensitivity to a very wide range of toxins.
The growth, harvesting and assessment of concentration of bacterial suspensions were carried out following previously published methods.9'12 Briefly, bacteria were grown on dialysis membranes overlain onto a plate of defined media'4 and incubated at 37°C for 18 hours. Bacteria and supra-membranous cell products were collected by washing with Hanks' balanced salt solution (HBSS) (Sigma, Poole, Dorset, UK) and the concentration of each bacterial suspension in HBSS was assessed using a double-beam spectrophotometer (PyeUnicam, Cambridge, UK) set at Xssnm. Bacterial suspensions were compared by adjusting the suspensions to a standardised and notional absorbance (where A=5-0), representing the undiluted sample. Bacteria were removed by centrifugation at 3000 x g for 20 minutes, then filter sterilisation using a 0X2 [tm pore membrane filter (Gelman Sciences, Michigan, USA). The concentration of each crude toxin preparation was considered to be the same as that of the original bacterial suspension from which it was derived. Toxin preparations were stored at -20°C and diluted as required with HBSS.
The biological activity of each crude toxin preparation was assessed by intravenous injection into 11-day old chick embryos. 9 13 Briefly, 50 p1 of each toxin preparation (at the desired concentration) was injected into the chorio-allantoic vein of each embryo. If injection resulted in haemorrhage, the embryo was replaced. The survival of each embryo post-injection was assessed after an 18 hours incubation period.
PRE-SYNERGY TOXICITY TESTING
Putative toxins from staphylococci were tested undiluted, and diluted (1 in 2, 1 in 4, 1 in 8, 1 in 16, and 1 in 32) with HBSS. Two separate toxin preparations from each individual bac- 7 and 11 produced TSST-1, and isolates 4, 5, 9, 10, and 13 produced neither detectable enterotoxin nor TSST-1. Staphylococcal strains isolated from SIDS victims predominantly produced SEC (four of seven isolates) compared with matched healthy controls (one of six isolates).
The pre-synergy experiments indicated that the lethality of each staphylococcal toxin preparation varied greatly, and that the concentrations of toxin preparations used in the subsequent synergy experiments ranged from undiluted to a dilution factor 1 in 8 of that of the original concentration (table 1) .
Endotoxin was used at a concentration of 1 ng/embryo (20 ng/ml) which killed 1 1 * 5 % of the embryos challenged (table 2) .
The expected effect of combining sub-lethal doses of staphylococcal toxins with endotoxin was originally estimated by a simple addition Endotoxin in SIDS 
